ArticleBritish journal of cancer2008

Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitro.

M K Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.